Cataracts are responsible for 51% of all blindness worldwide, affecting roughly 20 million people, so the impact is anything but small. From symptomatic cases dropping to 20/50 or worse in 80% of people to posterior subcapsular cataracts hitting the central 3 mm pupil area in 90% of advanced cases, the pattern is remarkably specific. We also look at how risk factors like smoking, diabetes, UV exposure, and obesity shift both onset and progression, alongside what modern phacoemulsification can realistically restore after surgery.
Key Takeaways
- Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases
- Nuclear cataracts cause myopic shift averaging -1.5D over progression
- Glare disability measured by 40% reduction in contrast sensitivity
- Globally, cataracts are responsible for 51% of all cases of blindness worldwide, affecting approximately 20 million people
- In the United States, about 24.4 million Americans aged 40 and older have cataracts, representing nearly half of this age group
- The prevalence of cataracts increases with age, reaching 50% in individuals over 75 years in developed countries
- Antioxidant supplements (vit C/E/beta-carotene) delay onset by 1.3 years in high-risk
- UV-protective sunglasses reduce risk by 40% with consistent outdoor use
- Smoking cessation lowers nuclear cataract risk by 6% per year quit
- Smoking increases cataract risk by 2-3 fold, particularly nuclear sclerosis type
- Diabetes doubles the risk of cataracts, with 4-year earlier onset in diabetics
- UV-B exposure raises posterior subcapsular cataract risk by 10% per decade of occupational exposure
- Phacoemulsification success rate 98.5% with IOL implantation restoring 20/40+ vision in 92%
- Postoperative best-corrected visual acuity (BCVA) 20/40 or better in 95.4% after 1 year
- Posterior capsule opacification (PCO) occurs in 20.7% within 5 years, treatable by YAG
Cataracts affect millions, often causing severe vision loss, but timely surgery and prevention can greatly help.
Related reading
01 · Category
Clinical Features And Diagnosis29 stats
01
Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases
02
Nuclear cataracts cause myopic shift averaging -1.5D over progression
03
Glare disability measured by 40% reduction in contrast sensitivity
04
Posterior subcapsular cataracts affect central 3mm pupil area in 90% advanced cases
05
LOCS III grading: Nuclear color >4.0 correlates with vision <20/40
06
Cortical cataracts involve >20% lens circumference in moderate cases
07
70% of patients report night driving difficulties as first symptom
08
Color vision deficiency in 25% with advanced nuclear sclerosis
09
Slit-lamp biomicroscopy detects 95% of immature cataracts
10
Pentacam imaging shows lens density >25 HU in 80% cataractous lenses
11
40% of cataracts show anterior chamber flare >1+ on diagnosis
12
Mature cataracts present with vision <20/200 in 85% cases
13
Capsular opacification causes 20/50 vision in 60% post-mature cataracts
14
Dilated pupil exam reveals spoke-like opacities in 75% cortical cataracts
15
Scheimpflug photography quantifies opacity progression at 0.5 LOCS/year
16
55% patients note reading vision decline first
17
Ultrasound biomicroscopy detects 10% anterior capsule irregularities
18
Contrast sensitivity loss >0.3 log units in 65% moderate cataracts
19
Hypermature cataracts show morgagnian globules in 30% aqueous
20
OCT lens imaging reveals 50% increased thickness in nuclear cataracts
21
35% report photophobia as prominent symptom
22
Retroillumination shows honeycomb pattern in 80% PSC cataracts
23
Visual field defects in 20% advanced cortical cataracts
24
Lens opacity meter >30 NDx indicates surgery need in 90%
25
45% have monocular diplopia complaint
26
Fundus view obscured in 70% dense cataracts
27
Straylight measurement >20 deg2 in 75% symptomatic cases
28
Polar cataracts present bilaterally in 95% pediatric cases
29
60% nuclear cataracts show brunescence (yellow-brown hue)
Interpretation
Clinical Features And Diagnosis Interpretation
Clinically, cataracts commonly lead to significant functional vision loss with 80% of symptomatic cases dropping to 20/50 or worse and glare causing a 40% reduction in contrast sensitivity, making early diagnosis especially important.
02 · Category
Epidemiology And Prevalence30 stats
01
Globally, cataracts are responsible for 51% of all cases of blindness worldwide, affecting approximately 20 million people
02
In the United States, about 24.4 million Americans aged 40 and older have cataracts, representing nearly half of this age group
03
The prevalence of cataracts increases with age, reaching 50% in individuals over 75 years in developed countries
04
In low- and middle-income countries, cataracts account for over 60% of blindness cases due to limited surgical access
05
Worldwide, an estimated 94 million people are blind from unoperated cataracts as of 2020 projections
06
In India, cataracts cause 62.6% of all blindness, with over 7 million blind individuals affected
07
Among women in the US, the prevalence of cataracts is 17.9% for ages 40-49, rising to 53.9% for ages 75 and older
08
In sub-Saharan Africa, cataract prevalence is 5.1% in people over 50, leading to 1.5 million blind cases
09
Europe reports a cataract surgery rate of 8.5 per 1,000 people aged 65+, highest in Western Europe at 10.2
10
In China, age-related cataracts affect 15.8% of those over 50, totaling over 100 million cases
11
Australian data shows 2.1 million people over 40 have cataracts, projected to double by 2030
12
In the UK, 29.8% of those aged 65-74 and 47.7% over 75 have cataracts
13
Brazil's national survey indicates 15.1% prevalence in adults over 50, with higher rates in rural areas
14
In Japan, posterior subcapsular cataracts prevalence is 10.2% in 60-69 year olds
15
South Korea reports 23.5% cataract prevalence in over 40s, with 4.1 million affected
16
In Canada, 2.4 million Canadians over 50 have visually significant cataracts
17
Egypt shows 17.3% prevalence of cataracts in rural populations over 50
18
In Russia, cataract incidence is 15.2 per 1,000 in elderly
19
Mexico's ENSANUT survey: 28.5% prevalence in 50+, higher in indigenous groups
20
In Iran, 12.4% of over 50s have cataracts, with 1.2 million blind
21
Turkey reports 14.7% prevalence in 40+
22
Nigeria: 1.1% blindness from cataracts in over 40s
23
In Pakistan, 77.5% of blindness in over 30s is cataract-related
24
Thailand: 8.6% prevalence in rural elderly
25
In Vietnam, 15.3% of over 50s affected
26
Philippines: Cataract surgery backlog of 1.2 million
27
In Saudi Arabia, 9.5% prevalence in over 40s
28
Argentina: 18.2% in 60+
29
In South Africa, 12.3% prevalence in black Africans over 50
30
Global projection: Cataract blindness to affect 32 million by 2025 without intervention
Interpretation
Epidemiology And Prevalence Interpretation
Cataracts dominate the epidemiology of blindness worldwide, causing 51% of all blindness and affecting about 20 million people globally while accounting for over 60% of blindness in low and middle income countries where surgical access is limited.
03 · Category
Prevention And Public Health27 stats
01
Antioxidant supplements (vit C/E/beta-carotene) delay onset by 1.3 years in high-risk
02
UV-protective sunglasses reduce risk by 40% with consistent outdoor use
03
Smoking cessation lowers nuclear cataract risk by 6% per year quit
04
Glycemic control (HbA1c <7%) halves cataract progression in diabetics
05
WHO Vision 2020 initiative performed 200 million surgeries 1999-2020
06
High vegetable intake (>3 servings/day) OR 0.7 for cortical cataracts
07
Blood pressure control <140/90 mmHg reduces risk by 25%
08
Cataract screening in >50s detects 70% operable cases early
09
Omega-3 intake >2g/day protective OR 0.65 for nuclear cataracts
10
Community outreach doubles surgery uptake in rural areas
11
Vitamin C serum >50 umol/L halves posterior subcapsular risk
12
Occupational eye protection prevents 80% UV-related opacities
13
AREDS formula slows progression by 25% in at-risk populations
14
Public awareness campaigns increase surgery rates by 35%
15
BMI maintenance 18.5-25 prevents 30% obesity-related cataracts
16
Annual dilated exams detect 90% pre-symptomatic cataracts
17
Alcohol moderation <1 drink/day OR 0.8 vs heavy drinkers
18
School eye screening prevents amblyopia from congenital cataracts in 95%
19
Fortified nutrition programs reduce malnutrition cataracts by 50% in kids
20
Telemedicine screening identifies 85% cataract referrals accurately
21
Lutein/zeaxanthin 10mg/day reduces nuclear density by 0.2 LOCS
22
Workplace wellness programs cut smoking prevalence 20%, lowering risks
23
Mobile surgery units serve 10x more underserved populations
24
Diabetes screening integrates with eye exams, preventing 40% complications
25
Hat + sunglasses combo 60% risk reduction for outdoor workers
26
Policy subsidies cover 70% surgery costs in LMICs, boosting access
27
Multivitamin use daily OR 0.75 for cataracts in men >50
Interpretation
Prevention And Public Health Interpretation
From a public health prevention perspective, the data suggest that simple, scalable behaviors such as consistent UV protection and smoking cessation can meaningfully cut cataract risk, including a 40% risk reduction with UV-protective sunglasses and a 6% lower nuclear cataract risk per year after quitting.
More related reading
04 · Category
Risk Factors26 stats
01
Smoking increases cataract risk by 2-3 fold, particularly nuclear sclerosis type
02
Diabetes doubles the risk of cataracts, with 4-year earlier onset in diabetics
03
UV-B exposure raises posterior subcapsular cataract risk by 10% per decade of occupational exposure
04
Obesity (BMI >30) associated with 1.7-fold increased risk of cortical cataracts
05
Corticosteroid use for >1 year increases posterior subcapsular cataract risk by 90%
06
Alcohol consumption >2 drinks/day linked to 1.23 RR for nuclear cataracts
07
Hypertension elevates cataract risk by 1.4 times, especially in women
08
Myopia > -6D increases risk of nuclear cataract by 3.3 times
09
Radiation exposure (e.g., Chernobyl workers) causes dose-dependent cortical opacities at 0.1 Gy
10
Chronic sunlight exposure without protection raises risk by 2.5 for cortical cataracts
11
Statin use may reduce cataract risk by 27% in long-term users
12
Female gender has 1.4 higher odds for nuclear cataracts after age 60
13
Serum HDL cholesterol <40 mg/dL associated with 1.6 RR for posterior cataracts
14
Occupational solvent exposure increases risk by 2.1 for posterior subcapsular
15
Genetic factors account for 50-60% heritability of age-related cataracts
16
Trauma causes 10-20% of unilateral cataracts in younger populations
17
Oral contraceptive use for >5 years raises risk by 1.3 for cortical cataracts
18
Chronic diarrhea/malnutrition increases risk 3-fold in developing countries
19
Atopic dermatitis patients have 1.6 higher risk of posterior subcapsular cataracts
20
Heavy metal exposure (lead, copper) linked to 2.4 RR for mixed cataracts
21
Shift work disrupting circadian rhythm increases risk by 1.4
22
High glycemic index diet correlates with 1.7 OR for nuclear opalescence
23
Previous retinal detachment surgery raises cataract risk to 30% within 2 years
24
HIV infection accelerates cataract formation 5-fold in untreated cases
25
Prolonged computer use (>8 hrs/day) associated with 1.3 OR for nuclear cataracts
26
Low antioxidant intake (vit C <125mg/day) increases risk by 1.5
Interpretation
Risk Factors Interpretation
Across these risk factors, diabetes stands out with a doubling of cataract risk and about a 4 year earlier onset, underscoring how metabolic disease can drive earlier cataract development.
05 · Category
Treatment And Surgical Outcomes30 stats
01
Phacoemulsification success rate 98.5% with IOL implantation restoring 20/40+ vision in 92%
02
Postoperative best-corrected visual acuity (BCVA) 20/40 or better in 95.4% after 1 year
03
Posterior capsule opacification (PCO) occurs in 20.7% within 5 years, treatable by YAG
04
Endothelial cell loss averages 8-15% at 6 months post-phaco
05
Multifocal IOLs achieve spectacle independence in 80% for distance/near
06
Complication rate <1% for posterior capsule rupture in high-volume surgeons
07
Visual recovery to preoperative potential in 91% after extracapsular surgery
08
Toric IOL corrects astigmatism >1.5D with 89% within 0.5D postoperative
09
Infection (endophthalmitis) rate 0.04-0.5 per 10,000 cases with prophylaxis
10
97% patient satisfaction rate post-uncomplicated cataract surgery
11
Femtosecond laser-assisted surgery reduces effective phaco energy by 40%
12
IOL power calculation accuracy within 0.5D in 85% using IOLMaster
13
Retinal detachment risk 0.7-1.2% within 5 years post-surgery
14
Extended depth of focus IOLs provide 20/25+ at 66cm in 92%
15
Postoperative cystoid macular edema in 1-2%, resolves in 90% with NSAIDs
16
Surgeon experience >1,000 cases reduces complications by 50%
17
Acrylic IOLs show 10% lower PCO rate vs PMMA at 3 years
18
Same-day bilateral surgery safe with 0.25% complication rate
19
Refractive surprise <1D in 93% with modern biometry
20
YAG capsulotomy effective in 95%, with BCVA improvement in 85%
21
Outpatient surgery recovery: 90% return to work in 1-3 days
22
Hydrophobic IOLs reduce PCO to 5% at 5 years vs hydrophilic 15%
23
Cost-effectiveness: Cataract surgery yields 27.5 QALYs gained per 1,000$
24
Pediatric cataract surgery with IOL: 85% axial length growth normal
25
Laser capsulotomy risk of retinal tear 1.5%
26
Premium IOLs increase satisfaction to 95% vs monofocal 85%
27
Zonular dehiscence managed intraop in 98% without vitrectomy
28
6-month BCVA stability in 96% uncomplicated cases
29
UV-blocking IOLs prevent 30% macular phototoxicity risk
30
Global surgery volume: 32 million procedures annually
Interpretation
Treatment And Surgical Outcomes Interpretation
In cataract treatment and surgical outcomes, phacoemulsification shows strong visual recovery with a 98.5% success rate and 92% reaching 20/40+ vision, while one year results remain excellent with 95.4% at 20/40 or better and low major complications with posterior capsule rupture under 1% in high-volume surgeons.
report visual · Key figures
Cataract impact on vision and imaging detection
Most cataract cases are strongly associated with reduced visual acuity and measurable functional or diagnostic changes.
80%
Symptomatic cataracts reduce visual acuity to 20/50 or worse in 80% of cases
85%
Mature cataracts present with vision <20/200 in 85% cases
18.2%
Argentina: 18.2% in 60+
95%
Slit-lamp biomicroscopy detects 95% of immature cataracts
90%
Lens opacity meter >30 NDx indicates surgery need in 90%
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Sophie Moreland. (2026, February 13). Cataract Statistics. Gitnux. https://gitnux.org/cataract-statistics
MLA
Sophie Moreland. "Cataract Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/cataract-statistics.
Chicago
Sophie Moreland. 2026. "Cataract Statistics." Gitnux. https://gitnux.org/cataract-statistics.
Sources & references
21 datasets cited across this report · attribution is report-level